{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:13:47Z","timestamp":1794964427226,"version":"4.9.1"},"reference-count":34,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81450047"],"award-info":[{"award-number":["81450047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81660468"],"award-info":[{"award-number":["81660468"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22168028"],"award-info":[{"award-number":["22168028"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PPL"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Gastric cancer has emerged as one of the major diseases threatening human\nhealth. Our previous studies indicated that the anti-cancer bioactive peptide (ACBP) inhibits\nthe initiation and progression of gastric cancer through apoptosis and cell cycle arrest, yet the\nmechanisms remain unclear. To elucidate the relationships between the effects of ACBP and the\nlevels of cell differentiation, as well as the functional mechanisms of ACBP, we conducted a\nstudy using three human gastric cancer cell lines: NCI-N87, MGC-803, and another unspecified\nline.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We investigated the impact of ACBP on the survival and morphology of these cancer\ncell lines, examined apoptosis and cell cycle progression, and detected the expression of TP53,\nTP63, and TP73 in cancer cells, as well as the expression of Bax, PUMA, and Mcl-1 in a xenograft\nmouse model. ACBP inhibited the proliferation of all three cancer cell lines in a dose-dependent\nmanner, similar to the positive control and 5-fluorouracil (5-FU). The effect of ACBP correlated\nwith the degree of differentiation of the cancer cells; the lower the differentiation degree, the\nstronger the inhibitory effect.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>After ACBP treatment, the expression of TP53, TP63, and TP73 increased in all cell lines.\nIn the xenograft mouse model, ACBP inhibited the growth of MGC-803 cells in vivo. The apoptotic-\nrelated genes Bax and PUMA were upregulated, while Mcl-1 was downregulated. ACBP inhibited\ntumor cell growth by inducing apoptosis through the TP53 signaling cascade, upregulating\nTP53, TP63, and TP73 and their downstream apoptosis-promoting genes Bax and PUMA while\ndownregulating the anti-apoptotic gene Mcl-1.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Notably, after ACBP treatment, Mcl-1 expression was significantly reduced in the tumor\ntissue of the xenograft model, indicating that ACBP induced apoptosis through the TP53 signaling\ncascade. This project provides a scientific basis for exploring the antitumor mechanism of\nACBP in gastric cancer therapy.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298665350654250111144722","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T08:09:17Z","timestamp":1739347757000},"page":"194-205","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Anti-Cancer Bioactive Peptide Induces Apoptosis in Gastric Cancer Cells through TP53 Signaling Cascade"],"prefix":"10.2174","volume":"32","author":[{"given":"Qimuge","family":"Suyila","sequence":"first","affiliation":[{"name":"Clinical Medical Research Center of the Affiliated Hospital, Inner Mongolia Bioactive Peptide Engineering Laboratory, Inner Mongolia Medical University, Hohhot 010050, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Li","sequence":"additional","affiliation":[{"name":"Clinical Medical Research Center of the Affiliated Hospital, Inner Mongolia Bioactive Peptide Engineering Laboratory,\nInner Mongolia Medical University, Hohhot 010050, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulan","family":"Su","sequence":"additional","affiliation":[{"name":"Clinical Medical Research Center of the Affiliated Hospital, Inner Mongolia Bioactive Peptide Engineering Laboratory,\nInner Mongolia Medical University, Hohhot 010050, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.21037\/cco-23-90","volume":"12","author":"Chen C.","year":"2023","unstructured":"Chen C.; Justo M.; Gangi A.; Hyperthermic intraperitoneal chemotherapy for gastric cancer: A narrative review. Chin Clin Oncol  2023,12(6),68","journal-title":"Chin Clin Oncol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10120-021-01242-0","volume":"25","author":"Furukawa K.","year":"2022","unstructured":"Furukawa K.; Hatakeyama K.; Terashima M.; Nagashima T.; Urakami K.; Ohshima K.; Notsu A.; Sugino T.; Yagi T.; Fujiya K.; Kamiya S.; Hikage M.; Tanizawa Y.; Bando E.; Kanai Y.; Akiyama Y.; Yamaguchi K.; Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE. Gastric Cancer  2022,25(1),138-148","journal-title":"Gastric Cancer"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"Jemal A.","year":"2011","unstructured":"Jemal A.; Bray F.; Center M.M.; Ferlay J.; Ward E.; Forman D.; Global cancer statistics. CA Cancer J Clin  2011,61(2),69-90","journal-title":"CA Cancer J Clin"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s10120-015-0538-4","volume":"19","author":"Kim Y.H.","year":"2016","unstructured":"Kim Y.H.; Kim J.H.; Kim H.; Kim H.; Lee Y.C.; Lee S.K.; Shin S.K.; Park J.C.; Chung H.S.; Park J.J.; Youn Y.H.; Park H.; Noh S.H.; Choi S.H.; Is the recent WHO histological classification for gastric cancer helpful for application to endoscopic resection? Gastric Cancer  2016,19(3),869-875","journal-title":"Gastric Cancer"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"Bray F.","year":"2024","unstructured":"Bray F.; Laversanne M.; Sung H.; Ferlay J.; Siegel R.L.; Soerjomataram I.; Jemal A.; Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2024,74(3),229-263","journal-title":"CA Cancer J Clin"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.bbrc.2005.08.084","volume":"336","author":"Cui R.","year":"2005","unstructured":"Cui R.; He J.; Mei R.; de Fromentel C.C.; Martel-Planche G.; Taniere P.; Hainaut P.; WITHDRAWN: Expression of p53, p63, and p73 isoforms in squamous cell carcinoma and adenocarcinoma of esophagus. Biochem Biophys Res Commun  2005,336(1),339-345","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1158\/1535-7163.MCT-12-1045","volume":"12","author":"Wang J.","year":"2013","unstructured":"Wang J.; Pursell N.W.; Samson M.E.S.; Atoyan R.; Ma A.W.; Selmi A.; Xu W.; Cai X.; Voi M.; Savagner P.; Lai C.J.; Potential advantages of CUDC-101, a multitargeted HDAC, EGFR, and HER2 inhibitor, in treating drug resistance and preventing cancer cell migration and invasion. Mol Cancer Ther  2013,12(6),925-936","journal-title":"Mol Cancer Ther"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/jcb.24711","volume":"115","author":"Yu L.","year":"2014","unstructured":"Yu L.; Yang L.; An W.; Su X.; Anticancer bioactive peptide-3 inhibits human gastric cancer growth by suppressing gastric cancer stem cells. J Cell Biochem  2014,115(4),697-711","journal-title":"J Cell Biochem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/CAD.0b013e32833b7598","volume":"21","author":"Yanagisawa M.","year":"2010","unstructured":"Yanagisawa M.; Yorozu K.; Kurasawa M.; Nakano K.; Furugaki K.; Yamashita Y.; Mori K.; Fujimoto-Ouchi K.; Bevacizumab improves the delivery and efficacy of paclitaxel. Anticancer Drugs  2010,21(7),687-694","journal-title":"Anticancer Drugs"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3892\/or.2017.5674","volume":"38","author":"Li X.","year":"2017","unstructured":"Li X.; Wu H.; Ouyang X.; Zhang B.; Su X.; New bioactive peptide reduces the toxicity of chemotherapy drugs and increases drug sensitivity. Oncol Rep  2017,38(1),129-140","journal-title":"Oncol Rep"},{"key":"ref=11","first-page":"3","volume":"23","author":"Su L.","year":"2010","unstructured":"Su L.; Xu G.; Shen J.; Tuo Y.; Zhang X.; Jia S.; Chen Z.; Su X.; Anticancer bioactive peptide suppresses human gastric cancer growth through modulation of apoptosis and the cell cycle. Oncol Rep  2010,23(1),3-9","journal-title":"Oncol Rep"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s13402-022-00666-9","volume":"45","author":"Zhang L.","year":"2022","unstructured":"Zhang L.; Su X.; Bioactive peptide inhibits acute myeloid leukemia cell proliferation by downregulating ALKBH5-mediated mA demethylation of EIF4EBP1 and MLST8 mRNA. Cell Oncol  2022,45(3),355-365","journal-title":"Cell Oncol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.2174\/0929866526666190405124955","volume":"26","author":"Li X.","year":"2019","unstructured":"Li X.; Xia L.; Ouyang X.; Suyila Q.; Su L.; Su X.; Bioactive peptides sensitize cells to anticancer effects of oxaliplatin in human colorectal cancer xenografts in nude mice. Protein Pept Lett  2019,26(7),512-522","journal-title":"Protein Pept Lett"},{"key":"ref=14","first-page":"39","volume":"2012","author":"Chernousov A.F.","year":"2012","unstructured":"Chernousov A.F.; Egorov A.V.; Chernousov F.A.; Levkin V.V.; Vychuzhanin D.V.; Kharlov N.S.; Stepanov S.N.; The use of Octreotide-depo for the pancreatitis\u2019 prophylaxis after radical surgery of gastric cancer with lymphadenectomy. Khirurgiia (Mosk)  2012,2012(8),39-43","journal-title":"Khirurgiia (Mosk)"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/CMAR.S387781","volume":"15","author":"Shen Q.","year":"2023","unstructured":"Shen Q.; Wang H.; Zhang L.; TP63 functions as a tumor suppressor regulated by GAS5\/miR-221-3p signaling axis in human non-small cell lung cancer cells. Cancer Manag Res  2023,15,217-231","journal-title":"Cancer Manag Res"},{"key":"ref=16","first-page":"201","volume":"43","author":"Xu Y.","year":"2020","unstructured":"Xu Y.; Li X.; Su X.; iTRAQ-based proteomics analysis of the therapeutic effects of combined anticancer bioactive peptides and oxaliplatin on gastric cancer cells. Oncol Rep  2020,43(1),201-217","journal-title":"Oncol Rep"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"111209","DOI":"10.1016\/j.biopha.2020.111209","volume":"137","author":"Tong X.","year":"2021","unstructured":"Tong X.; Zhuang Z.; Wang X.; Yang X.; Bai L.; Su L.; Wei P.; Su X.; ACBP suppresses the proliferation, migration, and invasion of colorectal cancer via targeting Wnt\/beta-catenin signaling pathway. Biomed Pharmacother  2021,137,111209","journal-title":"Biomed Pharmacother"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/aps.2015.80","volume":"36","author":"Su L.","year":"2015","unstructured":"Su L.; Shi Y.; Yan M.; Xi Y.; Su X.; Anticancer bioactive peptides suppress human colorectal tumor cell growth and induce apoptosis via modulating the PARP-p53-Mcl-1 signaling pathway. Acta Pharmacol Sin  2015,36(12),1514-1519","journal-title":"Acta Pharmacol Sin"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1749-6632.2009.04933.x","volume":"31","author":"Wang Y.F.","year":"2009","unstructured":"Wang Y.F.; Yan M.R.; Jia S.Q.; Liu G.R.; Su X.L.; Influence of the PCNA and Caspase-8 expression of anti-cancer bioactive peptide on experimental gastric cancer. Acta Acad Med Nei Mongol  2009,31,6-9","journal-title":"Acta Acad Med Nei Mongol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2045-3701-4-7","volume":"4","author":"Su X.","year":"2014","unstructured":"Su X.; Dong C.; Zhang J.; Su L.; Wang X.; Cui H.; Chen Z.; Combination therapy of anti-cancer bioactive peptide with Cisplatin decreases chemotherapy dosing and toxicity to improve the quality of life in xenograft nude mice bearing human gastric cancer. Cell Biosci  2014,4(1),7","journal-title":"Cell Biosci"},{"key":"ref=21","first-page":"270","volume":"2","author":"Jia S.Q.","year":"2007","unstructured":"Jia S.Q.; Wang W.L.; Su X.L.; Inhibitory effect of anti-cancer bioactive peptide on the proliferation of human breast cancer cell line nm231. Chin Med Biotechnol  2007,2,270-276","journal-title":"Chin Med Biotechnol"},{"key":"ref=22","first-page":"1557","volume":"17","author":"Wen Z.","year":"2011","unstructured":"Wen Z.; Su X.; Influence of p53 and Bcl-2 expression of anti-cancer bioactive peptide on experimental gastric cancer. Med Recapitulate  2011,17,1557-1559","journal-title":"Med Recapitulate"},{"key":"ref=23","first-page":"47","volume":"3","author":"Hu D.","year":"2004","unstructured":"Hu D.; Huang J.W.; Hu S.P.; Wang B.; Gao L.Y.; Expression and significance of the P53, P63 and P73 proteins in osteosarcoma. Chin J Bone Joint  2004,3,47-50","journal-title":"Chin J Bone Joint"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1365-2613.2009.00696.x","volume":"91","author":"Arcolino F.O.","year":"2010","unstructured":"Arcolino F.O.; Ribeiro D.L.; Gobbo M.G.; Taboga S.R.; G\u00f3es R.M.; Proliferation and apoptotic rates and increased frequency of p63-positive cells in the prostate acinar epithelium of alloxan-induced diabetic rats. Int J Exp Pathol  2010,91(2),144-154","journal-title":"Int J Exp Pathol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1309\/21TW-2NDG-JRK4-PFJX","volume":"116","author":"Kaufmann O.","year":"2001","unstructured":"Kaufmann O.; Fietze E.; Mengs J.; Dietel M.; Value of p63 and cytokeratin 5\/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol  2001,116(6),823-830","journal-title":"Am J Clin Pathol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/curroncol30020102","volume":"30","author":"Moreno J.","year":"2023","unstructured":"Moreno J.; Bahmad H.; Aljamal A.; Delgado R.; Salami A.; Guillot C.; Castellano-S\u00e1nchez A.; Medina A.; Sriganeshan V.; Prognostic significance of p53 and p63 in diffuse large b-cell lymphoma: A single-institution experience. Curr Oncol  2023,30(2),1314-1331","journal-title":"Curr Oncol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/sj.onc.1201500","volume":"15","author":"Schmale H.","year":"1997","unstructured":"Schmale H.; Bamberger C.; A novel protein with strong homology to the tumor suppressor p53. Oncogene  1997,15(11),1363-1367","journal-title":"Oncogene"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.3390\/cells11162516","volume":"11","author":"Rabow Z.","year":"2022","unstructured":"Rabow Z.; Laubach K.; Kong X.; Shen T.; Mohibi S.; Zhang J.; Fiehn O.; Chen X.; p73\u03b11, an isoform of the p73 tumor suppressor, modulates lipid metabolism and cancer cell growth via stearoyl-coa desaturase-1. Cells  2022,11(16),2516","journal-title":"Cells"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.jmb.2015.05.015","volume":"427","author":"Foight G.W","year":"2015","unstructured":"Foight G.W; Locating herpesvirus Bcl-2 homologs in the specificity landscape of anti-apoptotic Bcl-2 proteins. Mol Biol  2015,427(15),2468-2490","journal-title":"Mol Biol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e2266","DOI":"10.1038\/cddis.2016.167","volume":"7","author":"Zhang J.","year":"2016","unstructured":"Zhang J.; Huang K.; O\u2019Neill K.L.; Pang X.; Luo X.; Bax\/Bak activation in the absence of Bid, Bim, Puma, and p53. Cell Death Dis  2016,7(6),e2266","journal-title":"Cell Death Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/med.21379","volume":"36","author":"Liu Z.","year":"2016","unstructured":"Liu Z.; Ding Y.; Ye N.; Wild C.; Chen H.; Zhou J.; Direct activation of bax protein for cancer therapy. Med Res Rev  2016,36(2),313-341","journal-title":"Med Res Rev"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1371\/journal.pone.0126645","volume":"289","author":"Dai H.","year":"2015","unstructured":"Dai H.; Pang Y.P.; Evaluation of the BH3-only protein puma as a direct Bak activator. Biol Chem  2015,289(1),89-99","journal-title":"Biol Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"e0126645","DOI":"10.3390\/cells3020418","volume":"10","author":"Papaianni E.","year":"2014","unstructured":"Papaianni E.; El Maadidi S.; Schejtman A.; Phylogenetically distant viruses use the same BH3-only protein puma to trigger Bax\/Bak-dependent apoptosis of infected mouse and human cells. PLoS One  2014,10(6),e0126645","journal-title":"PLoS One"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/cells3020418","volume":"3","author":"Mojsa B.","year":"2014","unstructured":"Mojsa B.; Lassot I.; Desagher S.; Mcl-1 ubiquitination: Unique regulation of an essential survival protein. Cells  2014,3(2),418-437","journal-title":"Cells"}],"container-title":["Protein &amp; Peptide Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665350654250111144722","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/239295\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298665350654250111144722","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:46:07Z","timestamp":1747741567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/239295\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298665350654250111144722","relation":{},"ISSN":["0929-8665"],"issn-type":[{"value":"0929-8665","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}